Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other financing activities (2020 - 2021)

Arcutis Biotherapeutics has reported Other financing activities over the past 2 years, most recently at $1.6 million for Q4 2021.

  • Quarterly results put Other financing activities at $1.6 million for Q4 2021, up 447.56% from a year ago — trailing twelve months through Dec 2023 was $1.2 million (changed N/A YoY), and the annual figure for FY2022 was $2.2 million, up 33.6%.
  • Other financing activities for Q4 2021 was $1.6 million at Arcutis Biotherapeutics, up from -$471000.0 in the prior quarter.
  • Over the last five years, Other financing activities for ARQT hit a ceiling of $1.6 million in Q4 2021 and a floor of -$471000.0 in Q4 2020.